Thomas Callender

7.0k total citations · 3 hit papers
32 papers, 3.9k citations indexed

About

Thomas Callender is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas Callender has authored 32 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas Callender's work include Prostate Cancer Diagnosis and Treatment (4 papers), Cardiovascular and exercise physiology (3 papers) and Sports Performance and Training (2 papers). Thomas Callender is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (4 papers), Cardiovascular and exercise physiology (3 papers) and Sports Performance and Training (2 papers). Thomas Callender collaborates with scholars based in United Kingdom, United States and Australia. Thomas Callender's co-authors include Kazem Rahimi, Connor A. Emdin, Simon Anderson, Amit Kiran, Dena Ettehad, John Chalmers, Jonathan Emberson, Anthony Rodgers, Anushka Patel and Bruce Neal and has published in prestigious journals such as The Lancet, JAMA and Nature Medicine.

In The Last Decade

Thomas Callender

28 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

2015 2.2k citations Dena Ettehad, Connor A. Emdin et al. The Lancet profile →
Blood Pressure Lowering in Type 2 Diabetes

2015 510 citations Connor A. Emdin, Kazem Rahimi et al. profile →
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK

2022 222 citations Nathalie Conrad, Geert Verbeke et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Callender United Kingdom	17	2.1k	819	485	446	392	32	3.9k
Agustín J. Ramiréz Argentina	20	2.4k 1.1×	656 0.8×	503 1.0×	488 1.1×	434 1.1×	84	4.1k
Richard D. Wainford United States	19	2.1k 1.0×	644 0.8×	398 0.8×	611 1.4×	415 1.1×	54	3.8k
António Coca Spain	38	2.9k 1.4×	860 1.1×	563 1.2×	735 1.6×	520 1.3×	239	4.9k
Amit Kiran United Kingdom	16	1.8k 0.9×	464 0.6×	619 1.3×	387 0.9×	296 0.8×	26	3.0k
Giuliano Tocci Italy	32	2.1k 1.0×	700 0.9×	475 1.0×	408 0.9×	290 0.7×	212	3.7k
Teemu Niiranen Finland	38	3.1k 1.4×	432 0.5×	621 1.3×	496 1.1×	471 1.2×	193	4.5k
Isla S. Mackenzie United Kingdom	31	2.2k 1.0×	961 1.2×	799 1.6×	426 1.0×	329 0.8×	93	4.3k
David A. Wood United Kingdom	22	1.7k 0.8×	396 0.5×	687 1.4×	439 1.0×	459 1.2×	55	3.4k
Joshua D. Bundy United States	23	2.6k 1.2×	601 0.7×	370 0.8×	720 1.6×	833 2.1×	52	4.8k
N. Poulter United Kingdom	18	2.2k 1.0×	709 0.9×	505 1.0×	300 0.7×	433 1.1×	57	3.3k

Countries citing papers authored by Thomas Callender

Since Specialization

Citations

This map shows the geographic impact of Thomas Callender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Callender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Callender more than expected).

Fields of papers citing papers by Thomas Callender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Callender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Callender. The network helps show where Thomas Callender may publish in the future.

Co-authorship network of co-authors of Thomas Callender

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Callender. A scholar is included among the top collaborators of Thomas Callender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Callender. Thomas Callender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Callender, Thomas, et al.. (2026). The ethics of multi-cancer screening. Nature Medicine. 32(2). 407–409.

Callender, Thomas, Katherine Payne, Nora Pashayan, & Anne Mackie. (2025). Screening for multiple cancers: evaluation must go beyond aggregate measures. BMJ. 388. e081098–e081098. 1 indexed citations

Qian, Zhaozhi, et al.. (2024). Synthetic data for privacy-preserving clinical risk prediction. Scientific Reports. 14(1). 25676–25676. 9 indexed citations

Giddings, Rebecca, Thomas Callender, Sam M. Janes, et al.. (2024). Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic review. The Lancet Digital Health. 6(2). e131–e144. 21 indexed citations

Moore, Caroline M., Eleni Frangou, Neil McCartan, et al.. (2023). Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study. SHILAP Revista de lepidopterología. 2(1). e000057–e000057. 23 indexed citations

Callender, Thomas, Fergus Imrie, Nora Pashayan, et al.. (2023). Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study. PLoS Medicine. 20(10). e1004287–e1004287. 14 indexed citations

Callender, Thomas & Mihaela van der Schaar. (2023). Automated machine learning as a partner in predictive modelling. The Lancet Digital Health. 5(5). e254–e256. 8 indexed citations

Conrad, Nathalie, Geert Verbeke, Geert Molenberghs, et al.. (2022). Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. The Lancet. 400(10354). 733–743. 222 indexed citations breakdown →

Callender, Thomas, Mark Emberton, Stephen Morris, Paul D.P. Pharoah, & Nora Pashayan. (2021). Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer. JAMA Network Open. 4(3). e2037657–e2037657. 33 indexed citations

10.

Braithwaite, Isobel, Thomas Callender, Miriam Bullock, & Robert W Aldridge. (2020). Automated and partly automated contact tracing: a systematic review to inform the control of COVID-19. The Lancet Digital Health. 2(11). e607–e621. 217 indexed citations

11.

Callender, Thomas, et al.. (2020). Impact of advance care planning on dying in hospital: Evidence from urgent care records. PLoS ONE. 15(12). e0242914–e0242914. 17 indexed citations

12.

Callender, Thomas, Mark Emberton, Stephen Morris, et al.. (2019). Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study. PLoS Medicine. 16(12). e1002998–e1002998. 48 indexed citations

13.

Droney, Joanne, et al.. (2018). Advance care planning: the impact of Ceiling of Treatment plans in patients with Coordinate My Care. BMJ Supportive & Palliative Care. 9(3). 267–270. 11 indexed citations

14.

Emdin, Connor A., Thomas Callender, Jun Cao, & Kazem Rahimi. (2015). Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials. EP Europace. 17(5). 701–710. 30 indexed citations

15.

Emdin, Connor A., Simon Anderson, Thomas Callender, et al.. (2015). Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults. BMJ. 351. h4865–h4865. 97 indexed citations

16.

Emdin, Connor A., Thomas Callender, Jun Cao, John J.V. McMurray, & Kazem Rahimi. (2015). Meta-Analysis of Large-Scale Randomized Trials to Determine the Effectiveness of Inhibition of the Renin-Angiotensin Aldosterone System in Heart Failure. The American Journal of Cardiology. 116(1). 155–161. 31 indexed citations

17.

Ettehad, Dena, Connor A. Emdin, Amit Kiran, et al.. (2015). Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 387(10022). 957–967. 2249 indexed citations breakdown →

18.

Regmi, Sadie, et al.. (2014). Research and development funding for 13 neglected tropical diseases: an observational economic analysis. The Lancet. 384. S20–S20. 3 indexed citations

19.

Callender, Thomas, et al.. (2013). Strength in numbers? Grouping, fund allocation and coordination amongst the neglected tropical diseases. Journal of Global Health. 3(2). 20302–20302. 2 indexed citations

20.

Callender, Thomas, et al.. (1997). Neurotoxicity Associated with Occupational Exposure to Acetone, Methyl Ethyl Ketone, and Cyclohexanone. Environmental Research. 73(1-2). 181–188. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact